"Anticarcinogenic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.
| Descriptor ID |
D016588
|
| MeSH Number(s) |
D27.505.696.706.018 D27.505.954.248.125 D27.720.799.018
|
| Concept/Terms |
Anticarcinogenic Agents- Anticarcinogenic Agents
- Agents, Anticarcinogenic
- Anti-Carcinogenic Drugs
- Anti Carcinogenic Drugs
- Drugs, Anti-Carcinogenic
- Anticarcinogens
- Anti-Carcinogenic Agents
- Agents, Anti-Carcinogenic
- Anti Carcinogenic Agents
- Anticarcinogenic Drugs
- Drugs, Anticarcinogenic
Anticarcinogenic Effect- Anticarcinogenic Effect
- Effect, Anticarcinogenic
- Anti-Carcinogenic Effects
- Anti Carcinogenic Effects
- Effects, Anti-Carcinogenic
- Anticarcinogenic Effects
- Effects, Anticarcinogenic
- Anti-Carcinogenic Effect
- Anti Carcinogenic Effect
- Effect, Anti-Carcinogenic
|
Below are MeSH descriptors whose meaning is more general than "Anticarcinogenic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anticarcinogenic Agents".
This graph shows the total number of publications written about "Anticarcinogenic Agents" by people in this website by year, and whether "Anticarcinogenic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 4 | 0 | 4 |
| 2003 | 1 | 1 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 3 | 1 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticarcinogenic Agents" by people in Profiles.
-
Tomatoes, Lycopene, and Prostate Cancer: What Have We Learned from Experimental Models? J Nutr. 2022 06 09; 152(6):1381-1403.
-
?-Carotene 9',10' Oxygenase Modulates the Anticancer Activity of Dietary Tomato or Lycopene on Prostate Carcinogenesis in the TRAMP Model. Cancer Prev Res (Phila). 2017 Feb; 10(2):161-169.
-
Dietary tomato and lycopene impact androgen signaling- and carcinogenesis-related gene expression during early TRAMP prostate carcinogenesis. Cancer Prev Res (Phila). 2014 Dec; 7(12):1228-39.
-
Convergence of nanotechnology and cancer prevention: are we there yet? Cancer Prev Res (Phila). 2014 Oct; 7(10):973-92.
-
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10; 31(23):2942-62.
-
Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anticancer Agents Med Chem. 2012 Dec; 12(10):1264-80.
-
Current state and future challenges of chemoprevention. Discov Med. 2012 May; 13(72):385-90.
-
Phenformin as prophylaxis and therapy in breast cancer xenografts. Br J Cancer. 2012 Mar 13; 106(6):1117-22.
-
3,3'-Diindolylmethane suppresses growth of human esophageal squamous cancer cells by G1 cell cycle arrest. Oncol Rep. 2012 May; 27(5):1669-73.
-
Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor ?-dependent mechanism. Mol Pharmacol. 2012 Feb; 81(2):228-38.